# Mylab Discovery Solutions

Source: https://en.bioecon.ru/companies/mylab-discovery-solutions/
Updated: 2026-06-24

- Country: India

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Capacity | 200,000 RT-PCR and 50,000 RNA tests (as of 2020) | https://www.pib.gov.in/PressReleasePage.aspx?PRID=1641141 |
| Certification | ISO 9001, ISO 13485, WHO-GMP compliant, CE-IVD marked | https://biobase.whitefordresearch.com/companies/mylab-discovery-solutions, https://mylabglobal.com/about-mylab/, https://www.careratings.com/upload/CompanyFiles/PR/202505120547_Mylab_Discovery_Solutions_Private_Limited.pdf |
| Regulatory approval | CDSCO/India-FDA approved manufacturing facilities and products (including NAT, HIV, HBV, HCV, COVID-19) | https://mylabglobal.com/about-mylab/, https://www.careratings.com/upload/CompanyFiles/PR/202505120547_Mylab_Discovery_Solutions_Private_Limited.pdf, https://www.pib.gov.in/PressReleasePage.aspx?PRID=1641141 |
| Production site | Lonavala, Maharashtra (registered and main facility); Global Innovation Center in Baner, Pune (corporate office/R&D) | https://biobase.whitefordresearch.com/companies/mylab-discovery-solutions, https://mylabglobal.com/about-mylab/, https://www.thecompanycheck.com/company/mylab-discovery-solutions-private-limited/U74999PN2016PTC164780 |
| Headcount | 164 employees (as of May 1, 2025) | https://www.thecompanycheck.com/company/mylab-discovery-solutions-private-limited/U74999PN2016PTC164780 |
| Revenue | Between ₹100 crore and ₹500 crore (FY 2024) | https://www.thecompanycheck.com/company/mylab-discovery-solutions-private-limited/U74999PN2016PTC164780 |

Independent sources: biobase.whitefordresearch.com, careratings.com, mylabglobal.com, pib.gov.in, thecompanycheck.com

## Technologies

- [Diagnostics & biosensors](https://en.bioecon.ru/technology/diagnostics-biosensors/)